Browsing: Bio

Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer’s as a potential first indication. Longevity biotech…

Dyadic Applied BioSolutions expanded its collaboration with Fermbox Bio, a biotech research & manufacturing company developing and delivering bio-based products…

Rather than rely on conventional immunotherapies, Laguna Bio is betting on engineered microbes to enhance the immune response against cancer.…

Recipharm Advanced Bio, a segment of CDMO Recipharm, and Infant Bacterial Therapeutics (IBT) began a process performance qualification (PPQ) for…

Up-front payment of $55m targets new delivery methods for neurodegenerative disease treatments that cross the blood-brain barrier. Boston-based biotech Manifold…

Former Genentech, GRAIL execs form new diagnostics company powered by tissue-level biology, with longevity in its sights. Diagnostics startup Curve…

Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand…

Nearly a year after expanding from single cell omics solutions into spatial biology, Takara Bio USA has launched a series…

Longevity biotech seeks to broaden its therapeutic capabilities with cellular reprogramming and delivery technologies. Longevity-focused biotech Klotho Neurosciences revealed it…

Yokogawa Corporation of America and Repligen announce a collaboration to integrate Yokogawa’s OpreX Bio Pilot with Repligen’s MAVERICK ® ,…